GlassScriptPhysician profile
Jay T Heidecker
NPI 1609817675
$20,640.27
in general payments reported to CMS, 2019-2025
53 companies · $3,278 in 2025
The $3,278 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,858 · 2020: $1,367 · 2021: $1,478 · 2022: $2,826 · 2023: $3,790 · 2024: $5,042 · 2025: $3,278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,740 · Education: $1,600 · Travel and Lodging: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,740.05 |
| Education | $1,599.99 |
| Travel and Lodging | $770.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,572.47 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Intuitive Surgical, INC. | $2,215.96 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $1,978.27 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Mallinckrodt Hospital Products INC. | $1,231.90 | 2020-2025 | Acthar |
| Grifols USA, LLC | $1,091.64 | 2019-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $981.88 | 2019-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $916.24 | 2019-2025 | Dupixent |
| Medical Device Business Services, INC. | $820.32 | 2023 | Na |
| Takeda Pharmaceuticals U.S.A., INC. | $773.63 | 2020-2025 | Glassia |
| Actelion Pharmaceuticals US, INC. | $625.06 | 2019-2025 | Opsumit, Uptravi |
| United Therapeutics Corporation | $588.23 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Merck Sharp & Dohme LLC | $578.33 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Baxter Healthcare | $452.30 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $449.32 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $441.34 | 2019-2024 | Yupelri |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $440.55 | 2019-2025 | Xolair |
| Harmony Biosciences LLC | $419.22 | 2021-2025 | Wakix |
| Amgen INC. | $388.77 | 2021-2025 | Tezspire |
| Vifor Pharma, INC. | $385.68 | 2024-2025 | Zemaira |
| Genzyme Corporation | $336.28 | 2019-2025 | |
| Csl Behring | $331.49 | 2020-2025 | Hizentra |
| Insmed, INC. | $301.02 | 2019-2025 | Brinsupri, Arikayce |
| Gilead Sciences, INC. | $235.61 | 2021-2023 | |
| Jazz Pharmaceuticals INC. | $216.42 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $198.21 | 2023-2025 | Purified Cortrophin Gel |
| Mallinckrodt Enterprises LLC | $188.45 | 2019 | |
| La Jolla Pharmaceutical Company | $170.52 | 2021-2024 | Giapreza |
| Axsome Therapeutics, INC. | $166.73 | 2023-2025 | Sunosi |
| Novartis Pharmaceuticals Corporation | $160.55 | 2019-2023 | |
| Pulmonx Corporation | $113.49 | 2020-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Pfizer INC. | $93.95 | 2019-2024 | |
| Ethicon INC. | $87.79 | 2023-2025 | Monarch Platform |
| Electromed, INC. | $87.64 | 2021-2024 | Smartvest |
| Viatris Specialty LLC | $86.69 | 2025 | Yupelri |
| Janssen Pharmaceuticals, INC | $59.47 | 2019-2022 | |
| Varian Medical Systems, INC. | $46.62 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.86 | 2019-2023 | |
| Astellas Pharma US INC | $43.25 | 2023-2024 | Cresemba |
| Inogen, INC. | $34.60 | 2022-2023 | Inogen At Home Stationary Concentrator |
| Liquidia Technologies, INC. | $28.92 | 2025 | Yutrepia |
| Sunovion Pharmaceuticals INC. | $27.00 | 2019 | |
| Edwards Lifesciences Corporation | $25.64 | 2024 | Hemosphere |
| Shire North American Group INC | $25.48 | 2019 | |
| Inspire Medical Systems, INC. | $24.22 | 2025 | Inspire |
| Cook Medical LLC | $22.82 | 2019-2020 | |
| Lilly USA, LLC | $21.23 | 2025 | Zepbound |
| Verona Pharma, INC. | $20.67 | 2025 | Ohtuvayre |
| Getinge USA Sales, LLC | $19.64 | 2024 | Cardiosave Hybrid, Type B Plug |
| Abbvie INC. | $17.27 | 2023 | |
| Advanced Respiratory, INC | $15.14 | 2021 | |
| Allergan, INC. | $12.56 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $12.09 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Heidecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.